blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1455803

EP1455803 - USE OF PANTHENOL AND/OR PANTOTHENIC ACID AND HYALURONIC ACID AND/OR HYALURONATE FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR USE IN OPHTHALMOLOGY [Right-click to bookmark this link]
Former [2004/38]PHARMACEUTICAL COMPOSITION FOR USE IN OPHTHALMOLOGY AND RHINOLOGY
[2015/28]
StatusPatent maintained as amended
Status updated on  19.02.2016
Database last updated on 20.03.2026
Most recent event   Tooltip19.02.2016Patent maintained (B2 publication)published on 23.03.2016  [2016/12]
Applicant(s)For all designated states
URSAPHARM Arzneimittel GmbH & Co. KG
Industriestrasse
66129 Saarbrücken / DE
[2016/12]
Former [2004/38]For all designated states
URSAPHARM Arzneimittel GmbH & Co. KG
Industriestrasse
D-66129 Saarbrücken / DE
Inventor(s)01 / GROSS, Dorothea
Slevogtstrasse 32
66386 St. Ingbert / DE
02 / HOLZER, Frank
Auf Mühlental 3
66386 St. Ingbert / DE
 [2004/38]
Representative(s)Pfenning, Meinig & Partner mbB
Patent- und Rechtsanwälte
Theresienhöhe 11a
80339 München / DE
[2016/12]
Former [2012/05]Reitzle, Helmut
Pfenning, Meinig & Partner GbR
Patent- und Rechtsanwälte
Theresienhöhe 13
80339 München / DE
Former [2004/38]Walcher, Armin, et al
Louis, Pöhlau, Lohrentz & Segeth Postfach 3055
90014 Nürnberg / DE
Application number, filing date02794984.111.12.2002
[2004/38]
WO2002DE04527
Priority number, dateDE200116111012.12.2001         Original published format: DE 10161110
[2004/38]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO03049747
Date:19.06.2003
Language:DE
[2003/25]
Type: A1 Application with search report 
No.:EP1455803
Date:15.09.2004
Language:DE
The application published by WIPO in one of the EPO official languages on 19.06.2003 takes the place of the publication of the European patent application.
[2004/38]
Type: B1 Patent specification 
No.:EP1455803
Date:27.07.2005
Language:DE
[2005/30]
Type: B2 New European patent specification 
No.:EP1455803
Date:23.03.2016
Language:DE
[2016/12]
Search report(s)International search report - published on:EP19.06.2003
ClassificationIPC:A61K31/728, A61K31/16, A61P27/02
[2015/52]
CPC:
A61K31/728 (EP,US); A61P27/02 (EP); A61P27/04 (EP);
A61P27/14 (EP); A61P27/16 (EP); A61P43/00 (EP)
C-Set:
A61K31/728, A61K2300/00 (EP,US)
Former IPC [2004/38]A61K31/728, A61K31/16, A61P27/02, A61P27/16
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2016/12]
Former [2004/38]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  SI,  SK,  TR 
TitleGerman:VERWENDUNG VON PANTHENOL UND/ODER PANTHOTHENSÄURE UND HYALURONSÄURE/UND ODER HYALURONAT ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG ZUR OPHTALMOLOGISCHEN ANWENDUNG[2015/28]
English:USE OF PANTHENOL AND/OR PANTOTHENIC ACID AND HYALURONIC ACID AND/OR HYALURONATE FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR USE IN OPHTHALMOLOGY[2015/28]
French:UTILISATION DU PANTHENOL ET/OU D'ACIDE PANTOTHÉNIQUE OU D'ACIDE HYALURONIQUE ET/OU DE HYALURONATE POUR LA MANUFACTURE D'UNE COMPOSITION PHARMACEUTIQUE POUR UNE UTILISATION OPHTALMOLOGIQUE[2015/28]
Former [2004/38]PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR OPHTALMOLOGISCHEN UND RHINOLOGISCHEN ANWENDUNG
Former [2004/38]PHARMACEUTICAL COMPOSITION FOR USE IN OPHTHALMOLOGY AND RHINOLOGY
Former [2004/38]COMPOSITION PHARMACEUTIQUE POUR UNE UTILISATION OPHTALMOLOGIQUE ET RHINOLOGIQUE
Entry into regional phase22.05.2004National basic fee paid 
22.05.2004Designation fee(s) paid 
22.05.2004Examination fee paid 
Examination procedure22.05.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.05.2004Examination requested  [2004/38]
27.08.2004Despatch of a communication from the examining division (Time limit: M04)
23.09.2004Reply to a communication from the examining division
22.04.2005Communication of intention to grant the patent
25.05.2005Fee for grant paid
25.05.2005Fee for publishing/printing paid
26.09.2007Observations by third parties
20.12.2007Observations by third parties
Opposition(s)Opponent(s)01  09.01.2006  16.11.2006  WITHDRAWN
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH
Gereonsmühlengasse 1-11
50670 Köln / DE
Opponent's representative
Von Rohr Patentanwälte Partnerschaft mbB
Rüttenscheider Strasse 62
45130 Essen / DE
 [N/P]
Former [2013/03]
Opponent(s)01  09.01.2006  16.11.2006  WITHDRAWN
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH
Gereonsmühlengasse 1-11
50670 Köln / DE
Opponent's representative
Von Rohr
Patentanwälte Partnerschaft
Rüttenscheider Strasse 62
45130 Essen / DE
Former [2006/52]
Opponent(s)01  09.01.2006  16.11.2006  WITHDRAWN
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH
Gereonsmühlengasse 1-11
50670 Köln / DE
Opponent's representative
Strehlke, Ingo Kurt, et al, et al
Gesthuysen, von Rohr & Eggert Postfach 10 13 54
45013 Essen / DE
Former [2006/10]
Opponent(s)01  09.01.2006   
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH
Gereonsmühlengasse 1-11
50670 Köln / DE
Opponent's representative
Strehlke, Ingo Kurt, et al, et al
Gesthuysen, von Rohr & Eggert Postfach 10 13 54
45013 Essen / DE
01.06.2006Invitation to proprietor to file observations on the notice of opposition
07.12.2006Reply of patent proprietor to notice(s) of opposition
19.02.2008Date of oral proceedings
07.03.2008Despatch of minutes of oral proceedings
14.04.2008Despatch of communication that the patent will be revoked
27.01.2015Despatch of a communication from the opposition division (Time limit: M04)
22.05.2015Reply to a communication from the opposition division
07.07.2015Despatch of interlocutory decision in opposition
17.07.2015Legal effect of interlocutory decision in opposition
02.12.2015Despatch of communication that the patent will be maintained as amended
08.02.2016Fee for printing new specification paid
Appeal following opposition19.06.2008Appeal received No.  T1147/08
01.08.2008Statement of grounds filed
28.02.2012Result of appeal procedure: maintenance in amended form
28.02.2012Date of oral proceedings
02.03.2012Minutes of the oral proceedings despatched
Fees paidRenewal fee
10.11.2004Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipEE27.07.2005
IE27.07.2005
SI27.07.2005
TR27.07.2005
BG27.10.2005
DK27.10.2005
GR27.10.2005
CY11.12.2005
PT27.12.2005
MC31.12.2005
[2007/20]
Former [2007/11]EE27.07.2005
IE27.07.2005
SI27.07.2005
TR27.07.2005
BG27.10.2005
DK27.10.2005
GR27.10.2005
PT27.12.2005
MC31.12.2005
Former [2006/52]IE27.07.2005
SI27.07.2005
TR27.07.2005
BG27.10.2005
DK27.10.2005
GR27.10.2005
PT27.12.2005
MC31.12.2005
Former [2006/40]IE27.07.2005
SI27.07.2005
BG27.10.2005
DK27.10.2005
GR27.10.2005
PT27.12.2005
MC31.12.2005
Former [2006/26]IE27.07.2005
SI27.07.2005
BG27.10.2005
DK27.10.2005
GR27.10.2005
PT27.12.2005
Former [2006/25]IE27.07.2005
SI27.07.2005
BG27.10.2005
GR27.10.2005
PT27.12.2005
Former [2006/14]SI27.07.2005
BG27.10.2005
GR27.10.2005
PT27.12.2005
Former [2006/13]SI27.07.2005
BG27.10.2005
Cited inother  GEBHARD RIEGER: "Anti-oxidative capacity of various artificial tear preparations", GRAEFE'S ARCH CLIN EXP OPHTHALMOL, vol. 239, 2001, pages 222 - 226, XP003014992
Cited inOpposition  CONDON P.I. ET AL: "Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome", J. OPHTHALMOL, vol. 83, 1999, pages 1121 - 1124
   "Rote Liste 2000 Arzneimittelverzeichnis fr Deutschland (einschlielich EU-Zulassungen)", 2000, EDITIO CANTOR VERLAG, AULENDORF, pages: 72-004 - 72-121
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.